# Accuitive Medical Ventures

Accuitive Medical Ventures is a Venture Capital based in Atlanta, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Atlanta, United States
- **Region:** North America
- **Address:** Atlanta, GA, United States
- **Founded:** 2005
- **Assets under management:** $400M–$700M (Altss estimate)
- **Website:** accuitive.com
- **LinkedIn:** linkedin.com/company/accuitive-medical-ventures

## Regulatory record

- **Reports private funds:** No

## About

Accuitive Medical Ventures is a venture capital firm with $230 million in committed capital. The firm has offices in Palo Alto, CA, Atlanta, GA, Rochester, MN, and Fernandina Beach, FL. Accuitive Medical Ventures has made 85 investments, including a September 18, 2020 investment in ActivOrtho.

## Sectors

- Medical Devices
- Digital Health
- Healthcare Services
- Life Sciences

## People

- Charles Larsen — Managing Director
- Thomas O'Donnell — Managing Director
- Mark Wan — Managing Director

## Questions

### Who runs investment decisions at Accuitive Medical Ventures?

The firm is led by Managing Directors Charles Larsen, Thomas O'Donnell and Mark Wan, all former medical-device CEOs who founded and exited their own companies before joining the partnership. Investment decisions are made collectively by this operator group, reflecting the firm's requirement that every GP have CEO-level medtech operating experience.

### How does Accuitive source proprietary deal flow?

Accuitive's sourcing relies heavily on the operating networks of its general partners, each of whom spent decades in the medical-device industry before entering venture capital. The firm benefits from referrals through surgeon-specialist relationships, hospital-system administrators and regulatory consultants who worked with the partners during their operating careers.

### Is Accuitive structured more like a traditional venture firm or an operator-led vehicle?

Accuitive is definitively operator-led. The partnership's governing principle requires that every investment professional previously served as a medical-device CEO. This means portfolio companies receive board-level guidance from investors who have personally managed FDA submissions, manufacturing ramp-ups and hospital-contracting processes.

### Does Accuitive maintain a known posture on co-investments alongside external GPs?

Accuitive has historically co-invested alongside other medtech-focused venture firms and strategic corporate investors, particularly in later-stage rounds where syndicate construction involves multiple specialized funds. The firm does not publicly disclose a formal co-investment policy.

### Which sectors does Accuitive explicitly avoid?

Accuitive remains focused on regulated medical devices, diagnostics, digital health and healthcare services requiring FDA or equivalent regulatory pathways. The firm generally avoids pharmaceutical development, biotechnology and non-healthcare technology sectors, where its operator-partner expertise does not apply.

## Related profiles

- [Access Value Investors](https://altss.com/profile/access-value-investors)
- [Accum Capital](https://altss.com/profile/accum-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/accuitive-medical-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology